{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T04:14:23Z","timestamp":1692850463851},"reference-count":14,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1248\/bpb.b16-00918","type":"journal-article","created":{"date-parts":[[2017,4,30]],"date-time":"2017-04-30T22:07:46Z","timestamp":1493590066000},"page":"729-732","source":"Crossref","is-referenced-by-count":1,"title":["Elucidation of Distinct Roles of Guinea Pig CXCR1 and CXCR2 in Neutrophil Migration toward IL-8 and GRO\u03b1 by Specific Antibodies"],"prefix":"10.1248","volume":"40","author":[{"given":"Kento","family":"Tanaka","sequence":"first","affiliation":[{"name":"Biologics & Immuno-Oncology Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Yoshitomi","sequence":"additional","affiliation":[{"name":"End-Organ Disease Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Hirahara","sequence":"additional","affiliation":[{"name":"Biologics & Immuno-Oncology Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Bizzarri C, Beccari AR, Bertini R, Cavicchia MR, Giorgini S, Allegretti M. ELR+CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. <i>Pharmacol. Ther.<\/i>, <b>112<\/b>, 139\u2013149 (2006).","DOI":"10.1016\/j.pharmthera.2006.04.002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Stillie R, Farooq SM, Gordon JR, Stadnyk AW. The functional significance behind expressing two IL-8 receptor types on PMN. <i>J. Leukoc. Biol.<\/i>, <b>86<\/b>, 529\u2013543 (2009).","DOI":"10.1189\/jlb.0208125"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Yamamoto C, Yoneda T, Yoshikawa M, Fu A, Tokuyama T, Tsukaguchi K, Narita N. Airway inflammation in COPD assessed by sputum levels of interleukin-8. <i>Chest<\/i>, <b>112<\/b>, 505\u2013510 (1997).","DOI":"10.1378\/chest.112.2.505"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Traves SL, Culpitt SV, Russell REK, Barnes PJ, Donnelly LE. Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. <i>Thorax<\/i>, <b>57<\/b>, 590\u2013595 (2002).","DOI":"10.1136\/thorax.57.7.590"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Zhao X, Town JR, Li F, Zhang X, Cockcroft DW, Gordon JR. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels. <i>J. Immunol.<\/i>, <b>182<\/b>, 3213\u20133222 (2009).","DOI":"10.4049\/jimmunol.0800551"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Fricker M, Deane A, Hansbro PM. Animal models of chronic obstructive pulmonary disease. <i>Expert Opin. Drug Discov.<\/i>, <b>9<\/b>, 629\u2013645 (2014).","DOI":"10.1517\/17460441.2014.909805"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Catusse J, Faye P, Loillier B, Cremers B, Franck RM, Luccarini JM, Pruneau D, Paquet JL. Cloning and characterization of guinea pig interleukin-8 receptor. <i>Biochem. Pharmacol.<\/i>, <b>66<\/b>, 1171\u20131180 (2003).","DOI":"10.1016\/S0006-2952(03)00459-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Takahashi M, Jeevan A, Sawant K, McMurray DN, Yoshimura T. Cloning and characterization of guinea pig CXCR1. <i>Mol. Immunol.<\/i>, <b>44<\/b>, 878\u2013888 (2007).","DOI":"10.1016\/j.molimm.2006.03.023"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Yoshimura T, Johnson DG. cDNA cloning and expression of guinea pig neutrophil attractant protein-1 (NAP-1). NAP-1 is highly conserved in guinea pig. <i>J. Immunol.<\/i>, <b>151<\/b>, 6225\u20136236 (1993).","DOI":"10.4049\/jimmunol.151.11.6225"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yoshimura T, Takeya M, Ogata H, Yamashiro S, Modi WS, Gillitzer R. Molecular cloning of the guinea pig GRO gene and its rapid expression in the tissues of lipopolysaccharide-injected guinea pigs. <i>Int. Arch. Allergy Immunol.<\/i>, <b>119<\/b>, 101\u2013111 (1999).","DOI":"10.1159\/000024184"},{"key":"11","unstructured":"11) Tanaka K, Yoshimura C, Shiina T, Terauchi T, Yoshitomi T, Hirahara K. Generation and characterization of specific antibodies against guinea pig CXCR1 or CXCR2. <i>Monoclon. Antib. Immunodiagn. Immunother.<\/i>, in press."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Planagum\u00e0 A, Dom\u00e8nech T, Pont M, Calama E, Garc\u00eda-Gonz\u00e1lez V, L\u00f3pez R, Aul\u00ed M, L\u00f3pez M, Fonquerna S, Ramos I, de Alba J, Nueda A, Prats N, Segarra V, Miralpeix M, Lehner MD. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation. <i>Pulm. Pharmacol. Ther.<\/i>, <b>34<\/b>, 37\u201345 (2015).","DOI":"10.1016\/j.pupt.2015.08.002"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Jones SA, Wolf M, Qin S, Mackay CR, Baggiolini M. Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>93<\/b>, 6682\u20136686 (1996).","DOI":"10.1073\/pnas.93.13.6682"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Hammond ME, Lapointe GR, Feucht PH, Hilt S, Gallegos CA, Gordon CA, Giedlin MA, Mullenbach G, Tekamp-Olson P. IL-8 induces neutrophil chemotaxis predominantly <i>via<\/i> type I IL-8 receptors. <i>J. Immunol.<\/i>, <b>155<\/b>, 1428\u20131433 (1995).","DOI":"10.4049\/jimmunol.155.3.1428"}],"container-title":["Biological &amp; Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/5\/40_b16-00918\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T10:32:47Z","timestamp":1692786767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/5\/40_b16-00918\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-00918","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}